Bromoacetilalprenololmentan

S Vikipedije, slobodne enciklopedije
Bromoacetilalprenololmentan[1]
Skeletal formula of bromoacetylalprenololmenthane
Nazivi
IUPAC naziv
2-bromo--{N}--[2-[4-[[2-hidroksi- 3-(2-prop-2-enilfenoksi)propil]amino]- 4-metilcikloheksil]propan-2-il]acetamid
Identifikacija
3D model (Jmol)
Abrevijacija BrAAM
ChemSpider
MeSH Bromoacetylalprenololmenthane
  • CC(C)(NC(=O)CBr)C1CCC(C)(CC1)NCC(O)COC1=CC=CC=C1CC=C
  • BrCC(=O)NC(C2CCC(NCC(O)COc1ccccc1CC=C)(CC2)C)(C)C
Svojstva
C24H37BrN2O3
Molarna masa 481,48 g·mol−1
log P 4,14
Kiselost (pKa) 13,.844
Baznost (pKb) 0,153
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
ДаY verifikuj (šta je ДаYНеН ?)
Reference infokutije

Bromoacetilalprenololmentan (BAAM) je beta-adrenergički agonist.[4]

Reference[uredi | uredi izvor]

  1. ^ BrAAM - Compound Summary, PubChem.
  2. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  3. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  4. ^ Rainer-Joachim, Matthys Staehelin (20. 4. 1987). „Bromoacetylalprenololmenthane binding to β-receptors modulates the rate of hormone-induced internalization but not desensitization in S49 cells”. FEBS Letters. 214 (2): 323—326. 

Spoljašnje veze[uredi | uredi izvor]